» Articles » PMID: 21068324

Repeated Swim Impairs Serotonin Clearance Via a Corticosterone-sensitive Mechanism: Organic Cation Transporter 3, the Smoking Gun

Overview
Journal J Neurosci
Specialty Neurology
Date 2010 Nov 12
PMID 21068324
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with increased extracellular serotonin (5-HT) in limbic brain regions. The mechanism through which this occurs remains unclear. One way could be via HPA axis-dependent impairment of serotonin transporter (SERT) function, the high-affinity uptake mechanism for 5-HT. Consistent with this idea, we found that 5-HT clearance rate in hippocampus was dramatically reduced in mice exposed to repeated swim, a stimulus known to activate the HPA axis. However, this phenomenon also occurred in mice lacking SERT, ruling out SERT as a mechanism. The organic cation transporter 3 (OCT3) is emerging as an important regulator of brain 5-HT. Moreover, corticosterone, which is released upon HPA axis activation, blocks 5-HT uptake by OCT3. Repeated swim produced a persistent elevation in plasma corticosterone, and, consistent with prolonged blockade by corticosterone, we found that OCT3 expression and function were reduced in these mice. Importantly, this effect of repeated swim to reduce 5-HT clearance rate was corticosterone dependent, as evidenced by its absence in adrenalectomized mice, in which plasma corticosterone levels were essentially undetectable. Behaviorally, mice subjected to repeated swim spent less time immobile in the tail suspension test than control mice, but responded similarly to SERT- and norepinephrine transporter-selective antidepressants. Together, these results show that reduced 5-HT clearance following HPA axis activation is likely mediated, at least in part, by the corticosterone-sensitive OCT3, and that drugs developed to selectively target OCT3 (unlike corticosterone) may be candidates for the development of novel antidepressant medications.

Citing Articles

Organic cation transporters in psychiatric and substance use disorders.

Honan L, Fraser-Spears R, Daws L Pharmacol Ther. 2023; 253:108574.

PMID: 38072333 PMC: 11052553. DOI: 10.1016/j.pharmthera.2023.108574.


Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse.

Clauss N, Mayer F, Owens W, Vitela M, Clarke K, Bowman M Mol Psychiatry. 2023; 28(7):2934-2945.

PMID: 37308680 PMC: 10615754. DOI: 10.1038/s41380-023-02064-5.


Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.

Scholl J, Solanki R, Watt M, Renner K, Forster G Brain Res. 2022; 1800:148189.

PMID: 36462646 PMC: 9837808. DOI: 10.1016/j.brainres.2022.148189.


All the brain's a stage for serotonin: the forgotten story of serotonin diffusion across cell membranes.

Andrews P, Bosyj C, Brenton L, Green L, Gasser P, Lowry C Proc Biol Sci. 2022; 289(1986):20221565.

PMID: 36321487 PMC: 9627707. DOI: 10.1098/rspb.2022.1565.


Organic Cation Transporters in Psychiatric Disorders.

Daws L Handb Exp Pharmacol. 2021; 266:215-239.

PMID: 34282486 PMC: 9281871. DOI: 10.1007/164_2021_473.


References
1.
Blakely R, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A . Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 1998; 44(3):169-78. DOI: 10.1016/s0006-3223(98)00124-3. View

2.
Hirano K, Seki T, Sakai N, Kato Y, Hashimoto H, Uchida S . Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res. 2005; 1053(1-2):154-61. DOI: 10.1016/j.brainres.2005.06.038. View

3.
De Montigny C, CHAPUT Y, Blier P . Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry. 1990; 51 Suppl B:4-8. View

4.
Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y . Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett. 2005; 382(1-2):195-200. DOI: 10.1016/j.neulet.2005.03.014. View

5.
Engel K, Zhou M, Wang J . Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem. 2004; 279(48):50042-9. DOI: 10.1074/jbc.M407913200. View